1. A CD47‐blocking TRAIL fusion protein with dual pro‐phagocytic and pro‐apoptotic anticancer activity. (26th October 2013) Authors: Wiersma, Valerie R.; He, Yuan; Samplonius, Douwe F.; van, Robert J.; Gerssen, Jurjen; Eggleton, Paul; Zhou, Jin; Bremer, Edwin; Helfrich, Wijnand Journal: British journal of haematology Issue: Volume 164:Number 2(2014:Jan.) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein. Issue 4 (15th April 2016) Authors: Amoury, Manal; Mladenov, Radoslav; Nachreiner, Thomas; Pham, Anh‐Tuan; Hristodorov, Dmitrij; Di Fiore, Stefano; Helfrich, Wijnand; Pardo, Alessa; Fey, Georg; Schwenkert, Michael; Thepen, Theophilus; Kiessling, Fabian; Hussain, Ahmad F.; Fischer, Rainer; Kolberg, Katharina; Barth, Stefan Journal: International journal of cancer Issue: Volume 139:Issue 4(2016:Aug. 15) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint. (3rd August 2018) Authors: Koopmans, Iris; Hendriks, Djoke; Samplonius, Douwe F.; van Ginkel, Robert J.; Heskamp, Sandra; Wierstra, Peter J.; Bremer, Edwin; Helfrich, Wijnand Journal: Oncoimmunology Issue: Volume 7:Number 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members. Issue 1 (December 2017) Authors: He, Yuan; Bommel, Peter; Samplonius, Douwe; Bremer, Edwin; Helfrich, Wijnand Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation. (1st January 2020) Authors: Hendriks, Mark A. J. M.; Ploeg, Emily M.; Koopmans, Iris; Britsch, Isabel; Ke, Xiurong; Samplonius, Douwe F.; Helfrich, Wijnand Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles. (28th November 2021) Authors: Ploeg, Emily M.; Ke, Xiurong; Britsch, Isabel; Hendriks, Mark A.J.M.; Van der Zant, Femke A.; Kruijff, Schelto; Samplonius, Douwe F.; Zhang, Hao; Helfrich, Wijnand Journal: Cancer letters Issue: Volume 521(2021) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis. (1st January 2021) Authors: Hendriks, Mark A.J.M.; Britsch, Isabel; Ke, Xiurong; van Wijngarden, Anne P.; Samplonius, Douwe F.; Ploeg, Emily M.; Helfrich, Wijnand Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CD20-selective inhibition of CD47-SIRPα "don't eat me" signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab. (1st February 2018) Authors: van Bommel, Peter E.; He, Yuan; Schepel, Ilona; Hendriks, Mark A. J. M.; Wiersma, Valerie R.; van Ginkel, Robert J.; van Meerten, Tom; Ammatuna, Emanuele; Huls, Gerwin; Samplonius, Douwe F.; Helfrich, Wijnand; Bremer, Edwin Journal: Oncoimmunology Issue: Volume 7:Number 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Corrigendum: Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of 18F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging. Issue 23 (24th March 2021) Authors: Böhmer, Verena I.; Szymanski, Wiktor; van den Berg, Keimpe‐Oeds; Mulder, Chantal; Kobauri, Piermichele; Helbert, Hugo; van der Born, Dion; Reeβing, Friederike; Huizing, Anja; Klopstra, Marten; Samplonius, Douwe F.; Antunes, Ines F.; Sijbesma, Jürgen W. A.; Luurtsema, Gert; Helfrich, Wijnand; Viss... Journal: Chemistry Issue: Volume 27:Issue 23(2021) Page Start: 6993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Issue 2 (28th March 2016) Authors: Amoury, Manal; Kolberg, Katharina; Pham, Anh-Tuan; Hristodorov, Dmitrij; Mladenov, Radoslav; Di Fiore, Stefano; Helfrich, Wijnand; Kiessling, Fabian; Fischer, Rainer; Pardo, Alessa; Thepen, Theophilus; Hussain, Ahmad F.; Nachreiner, Thomas; Barth, Stefan Journal: Cancer letters Issue: Volume 372:Issue 2(2016) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗